Meadowlands Rejects Lady Shadow

%2F%2Flady-shadow-roses-are-red.jpg

The Meadowlands Racetrack is announcing that Lady Shadow, an earner of $1,915,777 and the 2016 Dan Patch Award winner as champion pacing mare, will be unable to race at the Meadowlands after a post-race test at Harrah’s Philadelphia on May 28 came back positive for Clenbuterol.

According to the ruling issued by the Pennsylvania Horse Racing Commission, “Ronald Adams as trainer is in violation of PHRC medication rules and the trainer responsibility rule. Mr. Adams has waived his hearing before the Judges and will appeal the ruling to the Racing Commission. All purse money earned on 5/28/2017 must be returned and redistributed. Transfers of horses must be approved by the Judges at Harrah’s Chester or by the PHRC.”

“As a result of the finding that Lady Shadow was found to have unacceptable levels of Clenbuterol when she raced at Harrah’s Philadelphia and the split sample came back positive, the owners have been advised that the horse will not be allowed to race in the upcoming stake at the Meadowlands,” said Meadowlands chairman Jeffrey Gural.

(with files from the Meadowlands)

Have something to say about this? Log in or create an account to post a comment.